Compass Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Compass Therapeutics's estimated annual revenue is currently $16.4M per year.
- Compass Therapeutics received $132.0M in venture funding in July 2018.
- Compass Therapeutics's estimated revenue per employee is $155,000
- Compass Therapeutics has 106 Employees.
- Compass Therapeutics grew their employee count by 14% last year.
- Compass Therapeutics currently has 1 job openings.
What Is Compass Therapeutics?
Were building Compass with a singular goal in mind: unlocking the complexity of the immune system. Our discovery and development teams work together to fully characterize and evaluate novel antibodies and rapidly generate therapeutic candidates. We are leveraging those insights to develop transformational therapies for cancer, inflammation and autoimmune diseases. We are a privately held company; our financing has been led by OrbiMed Advisors, F-Prime Capital, Cowen Healthcare Investments, Thiel Capital, Biomatics Capital, Borealis Ventures, Alexandria Real Estate Ventures and Biomed Realty Ventures. To learn more, visit www.compasstherapeutics.comkeywords:N/A